Pharsight

Drugs that contain Naftifine Hydrochloride

1. Naftin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8778365 SEBELA IRELAND LTD Topical compositions and methods for making and using same
Jan, 2033

(8 years from now)

US9161914 SEBELA IRELAND LTD Topical compositions and methods for making and using same
Jan, 2033

(8 years from now)

US10166206 SEBELA IRELAND LTD Topical compositions and methods for making and using same
Jan, 2033

(8 years from now)

US10166205 SEBELA IRELAND LTD Topical compositions and methods for making and using same
Jan, 2033

(8 years from now)

US10729667 SEBELA IRELAND LTD Topical compositions and methods for making and using same
Jan, 2033

(8 years from now)

US10695303 SEBELA IRELAND LTD Topical compositions and methods for making and using same
Jan, 2033

(8 years from now)

Market Authorisation Date: 27 June, 2013

Treatment: Treatment of fungal infections

Dosage: GEL;TOPICAL

How can I launch a generic of NAFTIN before it's drug patent expiration?
More Information on Dosage

NAFTIN family patents

Family Patents